Clinical Trial Update: Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 1]

View source ↗

Summary

Phase 1 study of Vinorelbine Liposome Injection for advanced solid tumors, Hodgkin lymphoma, and Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• Vinorelbine Liposome Injection (vinorelbine liposome)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Tumors, Hodgkins Disease | Phase 1 | Status: COMPLETED